Manna Molecular Science debuts women-focused CBD topical

Manna Molecular Science is bringing CBD into the sexual wellness space. The Worcester, Mass.-based hemp company has introduced Manna SX Vella, a topical serum the company said has shown the clinical efficacy of CBD in women’s sexual enhancement products. 

The company’s chief medical officer, urologist Harin Padma-Nathan, was a clinical trial investigator for Viagra who brought his expertise in the area to Manna. “We conducted organ bath studies to measure dose-response pharmacological effects, as well as at-home case studies among women,” Padma-Nathan said.

Manna CEO and co-founder Nial DeMena said that the company’s goal was to create a functional, effective product. “Our goal was to develop a CBD product that afforded tangible benefits to women,” he said. “The specific formulation is condom compatible and paraben-free.”

Manna SX Vella is offered in multiuse 200-mg CBD and single-use 20-mg
CBD formulations. The company said it plans to launch at major retailers, as well as dispensaries.